CJC-1295 W/O DAC 10MG

CJC-1295 NO DAC (Non-Decapeptidated) 10MG

CJC-1295 W/O DAC (Non-Decapeptidated) is a modified form of the synthetic peptide CJC-1295, which is a potent and well-studied analog of GHRH (Growth Hormone-Releasing Hormone). This version omits the decapeptide sequence, which may influence its stability and biological activity in specific research applications. This product is intended for use in academic, scientific, or specialized research environments where precise biochemical studies are conducted.

Research Context

CJC-1295 has been extensively investigated for its ability to stimulate the secretion of growth hormone (GH) from pituitary cells. Traditionally, CJC-1295 has been formulated with a decapeptide sequence that enhances its stability and bioavailability. The non-decapeptidated (NO DAC) variant may retain similar biological activity but could be particularly useful in settings where traditional formulations have limitations, such as in studies examining peptide degradation pathways or the impact of structural modifications on receptor engagement.

Research Overview

CJC-1295 W/O DAC is designed for researchers studying peptide hormone dynamics, receptor binding affinities, and the effects of structural modifications on biological outcomes. Because it lacks the decapeptide tail, this variant may exhibit differences in metabolic clearance, affinity for GHRH receptors, and potential for use in targeted experimental setups. Prior to use, researchers must ensure compliance with institutional guidelines and standard laboratory protocols for peptide handling.

Key Research Focus Areas

• Growth Hormone Stimulation Studies: Investigation of GH secretion in vitro or in animal models using CJC-1295 W/O DAC to compare its efficacy with decapeptidated forms.
• Peptide Stability and Degradation: Examination of metabolic processing and clearance rates in different biological matrices.
• Receptor Binding and Affinity: Assessing the interaction of CJC-1295 W/O DAC with GHRH receptors to evaluate structural requirements for biological activity.
• Comparative Pharmacokinetics: Contrasting the pharmacodynamics of CJC-1295 W/O DAC with decapeptidated variants to identify formulation-specific effects.
• Synthetic Chemistry and Purification: Studies focused on peptide synthesis techniques and purification methods for NO DAC formulations.

Safety and Compliance Note

This product is intended solely for research purposes in a controlled academic or institutional setting. Researchers must follow all applicable regulations, including those governing the storage, handling, and disposal of peptides and biopharmaceuticals. It is critical to conduct experiments in accordance with institutional review board (IRB) or ethics committee guidelines and to adhere to standard laboratory safety protocols. CJC-1295 W/O DAC should only be used in research environments where proper containment and biosafety measures are in place to mitigate potential risks.

For research use only. Not for human or animal consumption.